In vitro evaluation of antibiotic release from and bacteria growth inhibition by antibiotic‐loaded acrylic bone cement spacers
Authors:
- Jens KelmJKJens Kelm
- Eduard SchmittESEduard Schmitt
- 1 December 2004
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 72B (2) , 373-378
Abstract
The antibiotic release from and the bacteria growth inhibition by antibiotic‐loaded acrylic bone cement hip spacers were studied. The cement used was Palacos R, and it was loaded with either one antibiotic powder (gentamicin, vancomycin, teicoplanin, or synercid) [monoantibiotic case] or two antibiotic powders (gentamicin + vancomycin or gentamicin + teicoplanin) [biantibiotic case] and then tested against Staphylococcus epidermidis, Staphylococcus aureus, Enterococcus faecalis, and methicillin‐resistant Staphylococcus aureus (MRSA). Antibiotic elution and bacteria growth were measured every 24 h simultaneously by fluorescence polarization immunoassay and photometrically, respectively. The gentamicin + vancomycin combination achieved the longest growth inhibition on S. epidermidis and MRSA (mean of 20 and 14 days, respectively). Gentamicin + teicoplanin–loaded spacers were capable of inhibiting growth on E. faecalis and S. aureus for the longest period (11 and 16 days, respectively). The highest concentrations of gentamicin and vancomycin could be assayed during the first 4 days. Teicoplanin concentrations could be detected only during the first 72 h, synercid was not detected at all, possibly because of the limitation of the detection technique used. A greater percentage of the gentamicin was released than of the vancomycin. The aminoglycosid–glycopeptid combination showed a synergistic effect on the release of gentamicin, but not on vancomycin or teicoplanin. Biantibiotic‐impregnated hip spacers proved to be superior to monoantibiotic ones. Because of important differences between the conditions used for the present tests and the in vivo environment, any recommendation with regard to the use of monoantibiotic‐ and biantibiotic‐loaded acrylic bone cement spacers must await the results of further investigations. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 72B: 373–378, 2005Keywords
This publication has 13 references indexed in Scilit:
- Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplastyThe Journal of Arthroplasty, 2001
- Preformed acrylic bone cement spacer loaded with antibiotics: Use of two-stage procedure in 10 patients because of infected hips after total replacementActa Orthopaedica, 2001
- Emerging Antibiotic-Resistant BacteriaClinical Orthopaedics and Related Research, 1999
- Long-term elution of antibiotics from bone-cementThe Journal of Arthroplasty, 1998
- An intramedullary cement spacer in total hip arthroplastyThe Journal of Arthroplasty, 1998
- The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hipThe Journal of Arthroplasty, 1997
- Antibiotikaresistenz der Enterokokken in DeutschlandMedizinische Klinik - Intensivmedizin und Notfallmedizin, 1997
- Elution characteristics of vancomycin and tobramycin combined in acrylic bone—cementThe Journal of Arthroplasty, 1996
- In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin againstStaphylococcus aureus andStaphylococcus epidermidisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Bactericidal activity of teicoplanin in an in-vitro two-compartment kinetic modelJournal of Antimicrobial Chemotherapy, 1988